… Mary Alissa Willis contributed to design, analysis of data, manuscript preparation, manuscript
editing/review. Robert G. Wilson contributed to the design, analysis of data, and manuscript …

Purpose of Review: Many therapeutic advances for relapsing-remitting multiple sclerosis (MS)
have occurred in the past 25 years. Although similar advances in disease-modifying …

Objective. To assess the safety and efficacy of intrathecal baclofen (ITB) therapy for severe
spasticity in patients with upper–motor neuron predominant motor neuron disease (U-MND). …

Background The incidence of Pneumocystis jirovecii pneumonia (PJP) in patients with
underlying neurologic conditions is not well established, and the necessity of PJP prophylaxis for …

CONCLUSIONS • In this ongoing retrospective case series, satralizumab was effective and
well tolerated in patients with NMOSD, including those with concomitant autoimmune …

An 83-year-old man presented to the emergency department with acute, painless loss of
vision in his left eye. His vision in that eye had been normal in the middle of the night when he …

Purpose: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune
neuroinflammatory disease that primarily affects the optic nerves and spinal cord and can lead to …

Despite improved therapies for human immunodeficiency virus and central nervous system
cryptococcal infection, early mortality from human immunodeficiency virus-related …

Objective: To describe the response to satralizumab in adult patients with aquaporin 4
autoantibody–positive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD) in clinical …

Autoimmune inflammatory disorders are often marked by subacute development of new or
worsening symptoms. These relapses reflect active inflammation and should be promptly …